• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists.
Abstract In patients diagnosed with chronic kidney disease (CKD), atrial fibrillation (AF) is associated with an increased risk of thromboembolism and stroke. Moreover, patients with CKD - especially those in end-stage renal disease - also present an increased risk of bleeding. Oral anticoagulation is the most effective form of thromboprophylaxis in patients with AF and an increased risk of stroke. However, the underuse of these drugs was observed, mainly due to safety reasons and restricted evidence on efficacy. Much evidence suggests that non-vitamin K-dependent oral anticoagulant agents significantly reduce the...
Source: Cardiology Journal - March 25, 2019 Category: Cardiology Authors: Domienik-Karłowicz J, Tronina O, Lisik W, Durlik M, Pruszczyk P Tags: Cardiol J Source Type: research

Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2.0) for stroke prevention in atrial fibrillation.
CONCLUSIONS: This decision support tool can help optimise the use of antithrombotic therapy in patients with AF by considering risk versus benefit profiles and rationalising treatment selection. PMID: 28070883 [PubMed - as supplied by publisher]
Source: Cardiology Journal - January 9, 2017 Category: Cardiology Authors: Wang Y, Bajorek B Tags: Cardiol J Source Type: research

Evaluation of the impact of warfarin's time-in-therapeutic range on outcomes of patients with atrial fibrillation in Turkey: Perspectives from the Observational, Prospective WATER Registry.
CONCLUSIONS: WATER provides insights into the anticoagulation control status of AF patients in Turkey. The quality of anticoagulation was poor. Strategies should be undertaken by the clinician and patients to improve TTR. New oral anticoagulant agents may be ideal alternatives for NVAF patients. PMID: 26100825 [PubMed - as supplied by publisher]
Source: Cardiology Journal - June 23, 2015 Category: Cardiology Authors: Turk UO, Tuncer E, Alioglu E, Yuksel K, Pekel N, Ozpelit E, Vuran O, Tengiz I Tags: Cardiol J Source Type: research